Moditen (Fluphenazine Hydrochloride)

Fluphenazine hydrochloride works by blocking dopamine D2 receptors in the brain, which reduces excessive dopaminergic activity that contributes to psychotic symptoms. This antagonism also influences other neurotransmitter pathways, leading to a broader antipsychotic effect that stabilizes mood and perception.

The dosage of Moditen is individualized and determined by the prescribing clinician based on the patient’s condition, response, and tolerability. Physicians start with a low dose and may adjust it gradually; patients should follow the specific dosing instructions provided by their healthcare professional.

Safety data for fluphenazine hydrochloride in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To request Moditen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Moditen is a typical, high‑potency phenothiazine antipsychotic, whereas many newer agents are atypical antipsychotics with broader receptor profiles and often lower rates of extrapyramidal side effects. Fluphenazine offers strong dopamine D2 blockade, which can be advantageous for severe psychosis but may require careful monitoring for motor side effects.

Moditen should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Moditen is taken orally. The tablet should be swallowed whole with a full glass of water, preferably with or without food as directed by the prescriber. Patients should not crush, chew, or split the tablet unless specifically instructed by a healthcare professional.

The most serious risks include neuroleptic malignant syndrome—a rare but life‑threatening reaction characterized by fever, muscle rigidity, and autonomic instability—tardive dyskinesia, which may become permanent, and agranulocytosis, a severe drop in white‑blood‑cell count. Immediate medical attention is required if any of these symptoms appear.

Moditen is contraindicated in individuals with known hypersensitivity to fluphenazine or any phenothiazine component, patients with severe central nervous system depression, and those with a history of malignant hyperthermia. Caution is also advised for patients with uncontrolled cardiovascular disease, severe liver impairment, or a predisposition to extrapyramidal disorders.